Documente Academic
Documente Profesional
Documente Cultură
Age group
0-1w >180 >180 >180 >140 >130 >110
Tachycardia Bradycardia Respiratory b/min rate (breaths/mi n) <100 <100 <90 NA NA NA >50 >40 >34 >22 >18 >14
Leukocyte SBP count x1000/cu m >34 >19.5or <5 >17.5or <5 >15.5or <6 >13.5or <4,5 >11or <4,5 <65 <75 <100 <94 <105 <117
13 -< 18yr
Infection?
A suspected positive findings on clinical exam, chest radiograph consistent with pneumonia, petechial or purpuric rash, or purpura fulminans) proven (by positive culture, tissue stain, or polymerase chain reaction test). infection caused by any pathogen OR a clinical syndrome associated with a high probability of infection, perforated viscus.
Sepsis
SIRS in the presence of or as a result of suspected or proven infection.
Severe sepsis?
sepsis-induced tissue hypoperfusion or organ dysfunction
OR Two of the following Unexplained metabolic acidosis: base deficit>5.0 mEq/L Increased arterial lactate>2 times upper limit of normal Oliguria: urine output <0.5 mL/kg/hr Prolonged capillary refill >5 secs Core to peripheral temperature gap>3C
Platelet count _80,000/mm3 or a decline of 50% in platelet count from highest value recorded over the past 3 days (for chronichematology/oncology patients) OR International normalized ratio>2
Renal
Serum creatinine>2 times upper limit of normal for age or 2-fold increase in baseline creatinine
Hepatic
Total bilirubin>4 mg/dL (not applicable for newborn) OR ALT 2 times upper limit of normal for age
Septic shock
Septic shock Sepsis and cardiovascular organ dysfunction
Cardiovascular :
By far, the most significant physical findings in septic shock results from autonomic responses to stress. In children tachycardia occurs early. The younger the child, cardiac output is more dependent on heart rate rather than on increase in stroke volume. Alteration in blood pressure is a late manifestation of hypovolemia in children. Diastolic blood pressure begins to fall early as vascular tone begins to decrease. Systolic Blood pressure is well maintained initially and only begins to fall once hemodynamic compromise is severe. Decreasing blood pressure signifies decompensted stage of shock. In warm phase of septic shock capillary refill time may be normal, however signs of hyperdynamic circulation, widened pulse pressure, hyperdynamic apex beat are important signs. Capillary refill time of more than 5 seconds is always abnormal.
Respiratory:
Respiratory rate is increased to compensate for metabolic acidosis, secondly if ARDS is developing, progressive worsening of respiratory distress may occur.
Urine output
Oliguria is common leading to anuria.
GRADE of evidence
Grades of Recommendation, Assessment, Developmentand Evaluation (GRADE) system to
guide assessment of quality of evidence fromhigh (A) to very low (D) and to determine the strength of recommendations. A strong recommendation (1) indicates that an interventions desirable effects clearly outweigh its undesirable effects (risk, burden, cost) or clearly do not. Weak recommendations (2) indicate that the tradeoff between desirable and undesirable effects is less clear.
Dopamine :
It has alpha, beta and dopaminergic (delta) actions that are dose dependant. At low doses (<3 mcg/kg/min) it primarily causes weak renal and splanchnic vasodilatation, and at 3mcg to 10mcg/kg/min it exerts a positive myocardial inotropic efect. At higher doses (> 10 mcg/kg/min), it has strong vasoconstricting alpha effect, in addition to positive inotropic effect. So called 'Renal dose' of dopamine (2-5 mcg/kg/min) for renal vasolidation has been over emphasized and is of less practical significance in clinical setting. The primary indication for dopamine is the need to increase myocardial contractility after preload restoration. Usual dose is 5-20 mcg/kg/min titrated to desired effect. Dopamine(in doses>5 mcg/kg/min) should preferably, be given via central line to prevent ischemic necrosis of the skin.
Dobutamine
It is selective beta 1 agonist. It causes an increase in cardiac contractility and reduces peripheral resistance. The reduction in afterload and improved myocardial performance lowers ventricular filling pressures. Usual dose is 5mcg to 20mcg/kg/min. it should not be used alone in septic shock due to risk of further drop in blood pressure. Dopamine or adrenaline can be used to prevent hypotension due to vasoconstrictive effect.
Adrenaline(Epinephrine):
It is an alpha and beta adrenergic agonist. It is used in situations where dominant hemodynamic feature is peripheral vascular failure. At higher doses severe vasoconstriction can lead to lactic acidosis and renal and splanchnic ischemia. The usual dose is 0.1 mcg/kg/min to 1 mcg/kg/min. It should be titrated closely and minimum dose should be used for required
Noradrenaline (Norepinephrine):
An alpha and beta agonist (alpha> beta effect).Cardiac contractility is increased but it also causes massive increase in myocardial oxygen consumption and afterload, so cardiac output may not actually increase. Usual dose is 0.05 -1 mcg/ kg/ min. In severe septic shock with hypotension despite use of adrenaline secondary to intense vasodilatation, noradrenaline may be useful in increasing peripheral vascular resistance to improve blood pressure. Vasopressin In severe warm shock with hypotension resistant to noradrenaline,vasopressin may be tried.
Vasopressin
In severe warm shock with hypotension resistant to noradrenaline, vasopressin may be tried.
Afterload reduction
Caution should be used in using afterload reduction indiscriminately in septic shock without simultaneous inotropic support. Both nitroprusside and nitroglycerin lower systemic vascular resistence in children and are useful afterload reducing agents. These agents act via generation of nitric oxide. Nitroprusside has potent peripheral arterial vasodilating effects. Nitroglycerin is more potent venodilator and pulmonary vasodilator. Close monitoring and volume augmentation are frequently required when vasodilators are used to decrease pulmonary vascular resistance. Amrinone and milrinone are newer inotropic agents with properties of afterload reduction and myocardial diastolic relaxatione(10=12). Milrinone is commonly used for cardiogenic shock which is frequently associated with septic shock..
Fluid therapy
Fluid-resuscitate using crystalloids or colloids (1B) Target a CVP of 8 mm Hg (12 mm Hg if mechanically ventilated) (1C) Use a fluid challenge technique while associated with a hemodynamic improvement (1D) Give fluid challenges of 1000 mL of crystalloids or 300 500 mL of colloids over 30 mins. Morerapid and larger volumes may be required in sepsisinduced tissue hypoperfusion (1D) Rate of fluid administration should be reduced if cardiac filling pressures increase without concurrent hemodynamic improvement (1D)
Diagnosis
Obtain appropriate cultures before starting antibiotics provided this does not significantly delay antimicrobial administration.(1C) Obtain two or more blood cultures (BCs) One or more BCs should be percutaneous One BC from each vascular access device in place >48 hours Culture other sites as clinically indicated Perform imaging studies promptly in order to confirm and sample any source of infection if safe to do so. (1C)
Antibiotic therapy
Begin intravenous antibiotics as early as possible, and always within the first hour of recognizing severe sepsis (1D) and septicshock. (1B) Broad-spectrum: one or more agents active against likely bacterial/ fungal pathogens and with good penetration into presumed source. (1B) Reassess antimicrobial regimen daily to optimize efficacy, prevent resistance, avoid toxicity, & minimize costs. (1C) Consider combination therapy in Pseudomonas infections. (2D) Consider combination empiric therapy in neutropenic patients.(2D) Combination therapy no more than 3-5 days and de-escalation following susceptibilities. (2D) Duration of therapy typically limited to 710 days; longer if response slow, undrainable foci of infection, or immunologic deficiencies. (1D) Stop antimicrobial therapy if cause is found to be non-infectious. (1D)
Vasopressors
Maintain MAP 65 mm Hg (1C), what is The MAP Norepinephrine and dopamine centrally administered are the initial vasopressors of choice (1C) Epinephrine, phenylephrine, or vasopressin should not be administered as the initial vasopressor in septic shock (2C). Use epinephrine as the first alternative agent in septic shock when blood pressure is poorly responsive to norepinephrine or dopamine (2B). Do not use low-dose dopamine for renal protection (1A) In patients requiring vasopressors, insert an arterial catheter as soon as practical (1D)
Inotropic therapy
Use dobutamine in patients with myocardial dysfunction as supported by elevated cardiac filling pressures and low cardiac output (1C) Do not increase cardiac index to predetermined supranormal levels (1B)
Steroid
Consider intravenous hydrocortisone for adult septic shock when hypotension responds poorly to adequate fluid resuscitation and vasopressors (2C) ACTH stimulation test is not recommended to identify the subset of adults with septic shock who should receive hydrocortisone (2B) Hydrocortisone is preferred to dexamethasone (2B) Fludrocortisone (50 g orally once a day) may be included if an alternative to hydrocortisone is being used that lacks significant mineralocorticoid activity. Steroid therapy may be weaned once vasopressors are no longer required (2D)
Steroid
Hydrocortisone dose should be less than 300 mg/day (1A) Do not use corticosteroids to treat sepsis in the absence of shock unless the patients endocrine or corticosteroid history warrants it (1D)
Glucose control
Use intravenous insulin to control hyperglycemia in patients with severe sepsis following stabilization in the ICU (1B) Aim to keep blood glucose 150 mg/dL (8.3 mmol/L) using a validated protocol for insulin dose adjustment (2C) Provide a glucose calorie source and monitor blood glucose values every 12 hrs (4 hrs when stable) in patients receiving intravenous insulin (1C) Interpret with caution low glucose levels obtained with point of care testing, as these techniques may overestimate arterial blood or plasma glucose values (1B)
Bicarbonate therapy
Do not use bicarbonate therapy for the purpose of improving hemodynamics or reducing vasopressor requirements when treating hypoperfusioninduced lactic acidemia with pH 7.15 (1B)